Registered outcomes43

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

41 to 43 of 43

List	Outcome	Time frame	Description
Other	Change in Alanine Aminotransferase	Pre and post-intervention of 16 weeks	Serum alanine aminotransferase (ALT) concentration will be assessed as a clinical safety marker related to liver function.
Other	Change in Aspartate Aminotransferase	Pre and post-intervention of 16 weeks	Serum aspartate aminotransferase (AST) concentration will be assessed as a clinical safety marker related to liver function.
Other	Incidence of Adverse Events	Throughout the 16-week intervention.	Adverse events potentially associated with the aquatic exercise intervention or creatine/placebo supplementation will be recorded and clinically evaluated throughout the intervention period.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07914270/registered?page=3